Pharma Industry News

Alan J. Gelenberg, M.D., has joined Healthcare Technology Systems, Inc. (HTS) as President and CEO, bringing his decades of academic, clinical and executive medical experience.

Healthcare Technology Systems (www.healthtechsys.com), headquartered in Madison, Wisconsin, pioneered the development of clinical interactive voice response (IVR) systems to collect data directly from patients for pharmaceutical companies, healthcare organizations, and researchers. HTS also creates software to enhance patient care and clinical research in psychiatry and other specialties.

Dr. Gelenberg joins founding directors John H. Greist, M.D., James W. Jefferson, M.D., and David J. Katzelnick, M.D.

New Analysis by Applied Data Research Examines Recent Developments and Potential

(Nashua, NH) – In terms of the number of people affected, neurological diseases that contributed to decline in neuronal function are sometimes considered the newest healthcare epidemic. With the number of cases of neurodegenerative conditions expected to grow dramatically, driven by the aging population in developed countries, this therapeutic area represents one of the most compelling in both commercial and human terms. But the past few decades have been marked by optimistic pronouncements followed by clinical disappointments. As advances in genetics and target identification increase our understanding of the physiological basis of disease and cellular medicine, the search for a solution to neuronal protection is reaching into new clinical areas.

Greystone Associates Analyzes Technical and Commercialization Factors

(Amherst, NH) – Advances in materials processing - technologies that include micromachining, nanoprocessing and structured film forming - are creating new devices and new opportunities for minimally invasive medicine. These advances have led to the development and introduction of devices that employ very small needles – microneedles – that can deliver drugs or sample analyte by mechanically perforating the outer skin layer. The processing techniques incorporate one or more technologies that enable the precise machining, extrusion, casting, and/or forming of from one to an array or grid of microneedles.

November 22, 2007- Following a five-year investigation into the supply of counterfeit drugs over the internet, Operation Stormgrand concluded last month with the sentencing of Ashish Halai to four and a half years' imprisonment, at Kingston Crown Court. The operation found Halai guilty of bringing fake lifestyle medicines worth £millions into the UK from Asia both for sale and re-export. This case, and the announcement of counterfeit medicines being prescribed in the UK's NHS, has highlighted the growing trend in counterfeit drugs entering the pharmaceutical supply chain, into OTC pharmacies and for sale via the internet.